CRISPR And Cas Genes Market Research Report
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global CRISPR And Cas Genes Market, By Product & service
7.1. CRISPR And Cas Genes Market, by Product & service, 2021-2030
7.1.1. By Product
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. By Service
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global CRISPR And Cas Genes Market, By Application
8.1. CRISPR And Cas Genes Market, by Application, 2021-2030
8.1.1. Biomedical
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Agricultural
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global CRISPR And Cas Genes Market, By End User
9.1. CRISPR And Cas Genes Market, by End User, 2021-2030
9.1.1. Biotechnology & Pharmaceutical Companies
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Academics & Government Research Institutes
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Contract Research Organizations (CROs)
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global CRISPR And Cas Genes Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.1.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.2.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.3.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product & service (2016-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2030)
Chapter 11. Company Profiles
11.1. AstraZeneca plc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Addgene
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Caribou Biosciences, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Cellectis, CRISPR Therapeutics
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Editas Medicine, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. eGenesis
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. F. Hoffmann-La Roche Ltd.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Horizon Discovery Group plc
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. GenScript
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Danaher Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Intellia Therapeutics, Inc.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Lonza
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Merck KGaA
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Intellia Therapeutics, Inc.
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Takara Bio Inc.
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
11.16. Thermo Fisher Scientific, Inc.
11.16.1. Company Overview
11.16.2. Product Offerings
11.16.3. Financial Performance
11.16.4. Recent Initiatives
11.17. Synthego
11.17.1. Company Overview
11.17.2. Product Offerings
11.17.3. Financial Performance
11.17.4. Recent Initiatives
11.18. Mammoth Biosciences
11.18.1. Company Overview
11.18.2. Product Offerings
11.18.3. Financial Performance
11.18.4. Recent Initiatives
11.19. Inscripta, Inc.
11.19.1. Company Overview
11.19.2. Product Offerings
11.19.3. Financial Performance
11.19.4. Recent Initiatives
11.20. Cibus
11.20.1. Company Overview
11.20.2. Product Offerings
11.20.3. Financial Performance
11.20.4. Recent Initiatives
11.21. Beam Therapeutics
11.21.1. Company Overview
11.21.2. Product Offerings
11.21.3. Financial Performance
11.21.4. Recent Initiatives
11.22. PLANTeDIT
11.22.1. Company Overview
11.22.2. Product Offerings
11.22.3. Financial Performance
11.22.4. Recent Initiatives
11.23. Vertex Pharmaceuticals Incorporated
11.23.1. Company Overview
11.23.2. Product Offerings
11.23.3. Financial Performance
11.23.4. Recent Initiatives
11.24. Hera BioLabs
11.24.1. Company Overview
11.24.2. Product Offerings
11.24.3. Financial Performance
11.24.4. Recent Initiatives
11.25. OriGene Technologies, Inc.
11.25.1. Company Overview
11.25.2. Product Offerings
11.25.3. Financial Performance
11.25.4. Recent Initiatives
11.26. Recombinetics, Inc.
11.26.1. Company Overview
11.26.2. Product Offerings
11.26.3. Financial Performance
11.26.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers